SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

Autor: Loreto Carmona, Carlos Montilla, Ricardo Blanco, Ana Pérez, Íñigo Rúa-Figueroa, Celia Erausquin, Beatriz Tejera Segura, Javier Narváez, Irene Carrión-Barberà, Jorge Juan Fragío Gil, Raúl Menor-Almagro, Antonio Fernández-Nebro, Eva Tomero, Esther Ruiz-Lucea, Julia Martínez-Barrio, Gema Bonilla, Elena Aurrecoechea, María Jesús García-Villanueva, Eva Salgado, Mercedes Freire-González, Jaime Calvo Alen, Tatiana Cobo, María Galindo Izquierdo, Mónica Ibáñez-Barcelo, Loreto Horcada, Lorena Expósito, Joan M Nolla, Alejandro Muñoz-Jiménez, Jose L Andreu, Clara Sanguesa, Nuria Lozano-Rivas, Marta Arévalo, Carlota Iniguez, M Jesus García de Yébenes, Esther Uriarte Itzazelaia, José Carlos Rosas Gómez de Salazar, Silvia Gómez-Sabater, Claudia Moriano Morales, Vicente Torrente Segarra, Javier Nóvoa Medina, Angela Pecondón, Francisco J Toyos, Jose Oller, J M Pego-Reigosa

Publikováno v: Lupus Science and Medicine, Vol 11, Iss 1 (2024)

Objective To develop an improved score for prediction of severe infection in patients with systemic lupus erythematosus (SLE), namely, the SLE Severe Infection Score-Revised (SLESIS-R) and to validate it in a large multicentre lupus cohort.Methods We

Externí odkaz: https://doaj.org/article/74052532f2294dec9c5af1fe9c459c59

Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review

Autor: Diana Prieto-Peña, Pilar Bernabeu, Paloma Vela, Javier Narváez, Jesús C. Fernández-López, Mercedes Freire-González, Beatriz González-Álvarez, Roser Solans-Laqué, José L. Callejas Rubio, Norberto Ortego, Carlos Fernández-Díaz, Esteban Rubio, Salvador García-Morillo, Mauricio Minguez, Cristina Fernández-Carballido, Eugenio de Miguel, Sheila Melchor, Eva Salgado, Beatriz Bravo, Susana Romero-Yuste, Juan Salvatierra, Cristina Hidalgo, Sara Manrique, Carlos Romero-Gómez, Patricia Moya, Noelia Álvarez-Rivas, Javier Mendizabal, Francisco Ortiz-Sanjuán, Iván Pérez de Pedro, José L. Alonso-Valdivielso, Laura Perez-Sanchez, Rosa Roldán, Nagore Fernandez-Llanio, Ricardo Gómez de la Torre, Silvia Suarez, María Jesús Montesa Cabrera, Mónica Delgado Sánchez, Javier Loricera, Belén Atienza-Mateo, Santos Castañeda, Miguel A. González-Gay, Ricardo Blanco

Publikováno v: Therapeutic Advances in Musculoskeletal Disease, Vol 13 (2021)

Objective: To assess the efficacy and safety of tocilizumab (TCZ) in Caucasian patients with refractory Takayasu’s arteritis (TAK) in clinical practice. Methods: A multicenter study of Caucasian patients with refractory TAK who received TCZ. The ou

Externí odkaz: https://doaj.org/article/d3daa2f8a9974d32bf3007562457a783

Development of an application for mobile phones (App) based on the collaboration between the Spanish Society of Rheumatology and Spanish Society of Family Medicine for the referral of systemic autoimmune diseases from primary care to rheumatology

Autor: María Medina-Abellán, Juan José Alegre-Sancho, Ana Urruticoechea-Arana, Juan Carlos Hermosa-Hernán, Jose Luis Andreu-Sanchez, Xavier Mas-Garriga, José Andrés Román-Ivorra, Mercedes Freire-González, Fernando León-Vázquez, E. Beltrán-Catalán, Tatiana Cobo-Ibáñez, Jordi Forcada-Gisbert, Ricardo Blanco-Vela, Francisco Vargas-Negrín, Vicente Giner-Ruiz, Carmen Costa-Ribas, María Victoria Hernández-Miguel, Enrique Nieto-Pol, José M. Pego-Reigosa, Alejandro Olivé-Marqués, Iñigo Rúa-Figueroa, Santiago Muñoz-Fernández, Jaime Calvo-Alén, Javier Narváez-García, Álvaro Pérez-Martín

Publikováno v: Reumatologia Clinica
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-FISABIO. Repositorio Institucional de Producción Científica

Management of systemic autoimmune diseases is challenging for physicians in their clinical practice. Although not common, they affect thousands of patients in Spain. The family doctor faces patients with symptoms and non-specific cutaneous, mucous, j

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d72f93d733f130c2ed8a146a095f3b2
https://doi.org/10.1016/j.reumae.2019.09.001

Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality

Autor: Esther Ruiz-Lucea, Esther Uriarte-Isacelaya, Raúl Menor-Almagro, Elena Aurrecoechea, Leyre Riancho-Zarrabeitia, Juan Ovalles, José Ángel Hernández-Beriain, Mercedes Freire-González, Víctor M. Martínez-Taboada, Javier Narváez-García, F. J. Alonso, Jaime Calvo-Alén, Alejandro Olivé-Marqués, Iñigo Rúa-Figueroa, Loreto Horcada, María Galindo-Izquierdo, Carlos Galisteo, Alina Botenau, Eva Tomero-Muriel, Gregorio Santos Soler, Lorena Expósito, Enrique Raya, Antonio Fernández-Nebro, Ivan Castellví, Mariano Andrés, Víctor Quevedo Vila, Mónica Ibáñez-Barcelo, José M. Pego-Reigosa

Publikováno v: LUPUS
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-FISABIO. Repositorio Institucional de Producción Científica
r-IIB SANT PAU: Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
Lupus
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol

Introduction Antiphospholipid antibodies (aPL) have been associated with organ damage and certain features in systemic lupus erythematosus(SLE) patients. Our aim was to investigate the differences between SLE patients according to the presence of aPL

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::934a6e0df209d96fc894cee1aaf9e133
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=6612

Pulmonary Alveolar Proteinosis in a Patient with Systemic Lupus Erythematosus

Autor: Maite Silva-Díaz, Mercedes Freire González, Teresa Hermida Romero

Publikováno v: The Journal of Rheumatology. 47:779-780

Secondary pulmonary alveolar proteinosis (PAP) associated with treatment is relatively frequent1,2. However, PAP associated with autoimmune diseases is extremely rare; we have found only 2 cases reported in the literature1,3. We present a 34-year-old

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ecb38ff615de2c33e9686112dfe4e5b
https://doi.org/10.3899/jrheum.181410